This markers are particularly useful in determining the multiplicity of infection (MOI), a measure of the effectiveness of intervention programmes and also msp-1 and msp-2 typing are widely used in anti-malarial drug efficacy trials to distinguishing recrudescent parasites from new infections [15–17]. This evidence concerns the gene ATAD1 and infection.